Literature DB >> 18583193

Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thrombelastograph (TEG).

Pär I Johansson1, Louise Bochsen, Jakob Stensballe, Niels H Secher.   

Abstract

We investigated the effect of administering a transfusion package encompassing 5 red blood cells (RBC), 5 fresh frozen plasma (FFP), and 2 platelet concentrates (PC) on clot formation and stability as evaluated by Thrombelastograph (TEG) in 10 patients presenting with massive bleeding. Blood was obtained before and after administering the transfusion packages. Six patients were hypocoagulable before administration of the transfusion package, whereas none of the patients were hypocoagulable after transfusion of up to 7 transfusion packages (p=0.01). In 8 patients damage control surgery was successful and 6 of these patients survived. The result indicates that an early balanced transfusion strategy maintains haemostatic competence in massively bleeding patients.

Entities:  

Mesh:

Year:  2008        PMID: 18583193     DOI: 10.1016/j.transci.2008.05.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  10 in total

1.  Practical understanding of hemostasis and approach to the bleeding patient in the OR.

Authors:  Albert Pierce; Jean-Francois Pittet
Journal:  Adv Anesth       Date:  2014

2.  A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.

Authors:  Elisa A Ferrante; Kiev R Blasier; Thomas B Givens; Cynthia A Lloyd; Timothy J Fischer; Francesco Viola
Journal:  Anesth Analg       Date:  2016-12       Impact factor: 5.108

3.  Blood product ratio in acute traumatic coagulopathy--effect on mortality in a Scandinavian level 1 trauma centre.

Authors:  Jesper Dirks; Henrik Jørgensen; Carsten H Jensen; Sisse R Ostrowski; Pär I Johansson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-12-07       Impact factor: 2.953

Review 4.  Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.

Authors:  Pär I Johansson; Sisse R Ostrowski
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

5.  Clinical observation study of massive blood transfusion in a tertiary care hospital in Korea.

Authors:  Seoyoung Yoon; Ae Ja Park; Hyun Ok Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

6.  Reduced clot strength upon admission, evaluated by thrombelastography (TEG), in trauma patients is independently associated with increased 30-day mortality.

Authors:  Kristin B Nystrup; Nis A Windeløv; Annemarie B Thomsen; Pär I Johansson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-09-28       Impact factor: 2.953

7.  Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.

Authors:  Herbert Schöchl; Ulrike Nienaber; Marc Maegele; Gerald Hochleitner; Florian Primavesi; Beatrice Steitz; Christian Arndt; Alexander Hanke; Wolfgang Voelckel; Cristina Solomon
Journal:  Crit Care       Date:  2011-03-04       Impact factor: 9.097

8.  Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study.

Authors:  P I Johansson; J Stensballe
Journal:  Vox Sang       Date:  2009-02       Impact factor: 2.144

Review 9.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

10.  TEG® and ROTEM® in trauma: similar test but different results?

Authors:  Ajith Sankarankutty; Bartolomeu Nascimento; Luis Teodoro da Luz; Sandro Rizoli
Journal:  World J Emerg Surg       Date:  2012-08-22       Impact factor: 5.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.